AHZ 9.23% 7.1¢ admedus ltd

half yearly upside

  1. 1,164 Posts.
    lightbulb Created with Sketch. 12
    compared to the last quarterly the half yearly will show research tax credits and money owed for cardiocel sales made through to the end of December. Further, it is a prime opportunity for the company to outline any product developments or hint at how things have progressed over January and February.

    looks like post quarterly pessimism has worn itself out. Getting some good volumes with no sign of a push below .105.

    I've taken the opportunity to add to my position at .11, putting my money where my mouth is. My opinion is that we are consolidating ahead of the next major push up over the following few months. Hopefully it will be as spectacular at the push up from .02
 
watchlist Created with Sketch. Add AHZ (ASX) to my watchlist
(20min delay)
Last
7.1¢
Change
0.01(9.23%)
Mkt cap $22.93M
Open High Low Value Volume
6.5¢ 7.1¢ 6.5¢ $99.76K 1.468M

Buyers (Bids)

No. Vol. Price($)
1 4400 6.7¢
 

Sellers (Offers)

Price($) Vol. No.
7.1¢ 70000 2
Last update - 15.58pm 11/12/2018 (20 minute delay) ?
(live)
Last
6.9¢
  Change
0.01 ( 6.15 %)
Open High   Low Volume
6.7¢ 6.9¢   6.5¢ 404208
Last updated 15.18pm 11/12/2018 (live) ?
AHZ (ASX) Chart
GET SUPPORT arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.